Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT00107939 Completed - Bipolar Disorder Clinical Trials

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and tolerability of an investigational drug for the treatment of manic episodes of bipolar disorder. The investigational drug will be given as additional therapy to one of the five following medications: risperidone, olanzapine, quetiapine, ziprasidone, or aripiprazole. These medications are already FDA (Food and Drug Administration)-approved treatments for mania.

NCT ID: NCT00107926 Completed - Bipolar Disorder Clinical Trials

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and tolerability of an investigational drug for the treatment of manic episodes of bipolar disorder. The investigational drug will be given as additional treatment with either lithium or valproate, which are already FDA (Food and Drug Administration)-approved treatments for mania.

NCT ID: NCT00107731 Completed - Bipolar I Disorder Clinical Trials

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Start date: April 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar I Disorder. The study consists of enrollment and 2 phases, the Open-label treatment Phase and the Randomized treatment Phase. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00106223 Completed - Clinical trials for Somatoform Disorders

Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder

Start date: April 2004
Phase: N/A
Study type: Interventional

In an earlier phase of this study, a cognitive behavioral therapy (CBT) manual to treat body dysmorphic disorder (BDD) symptoms was developed. We are currently implementing this manual-based treatment to validate its effectiveness in patients with BDD.

NCT ID: NCT00105911 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD

Start date: July 2002
Phase: N/A
Study type: Interventional

The literature and our preliminary studies found that in COPD patients, psychosocial factors affect quality of life (QOL) and functioning more than would be expected given the severity of their disease. To improve QOL and functioning in the approximately 50% of COPD patients with significant anxiety and/or depressive symptoms, interventions are needed. Much research documents the utility of cognitive behavioral therapy (CBT) in treating depression and anxiety, showing it to have promise as a self-management intervention to improve QOL in COPD patients.

NCT ID: NCT00105885 Completed - Anxiety Disorders Clinical Trials

Telephone Care as a Substitute for Routine Psychiatric Medication

Telepsych
Start date: November 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to answer the following questions: (1) Does substituting brief, scheduled, clinician-initiated telephone calls (telephone care) for routine psychiatric medication management visits reduce overall healthcare utilization? (2) Is substituting brief, scheduled, clinician-initiated telephone calls (telephone care) for routine psychiatric medication management visits as effective as routine care?

NCT ID: NCT00105794 Completed - Schizophrenia Clinical Trials

Psychiatric Advance Directives for Improved Mental Health Care

Start date: March 2004
Phase: N/A
Study type: Interventional

During a psychiatric crisis, persons with severe mental illness (SMI) confront complex challenges concerning treatment choices and are often ill equipped or unable to make mental health care decisions. Psychiatric Advance Directives (PADs) are legal documents that allow competent persons to declare their treatment preferences in advance of a mental health crisis, when they may lose capacity to make reliable health care decisions. The use of PADs is consistent with recommendations of the President�s New Freedom Commission on Mental Illness and the Patient Self-Determination Act; 25 states have now adopted PAD legislation. VA does not have a specific policy for PADs or mechanisms to notify veterans of their right to prepare PADs. The downstream effects of PADs on patient care, crisis management, service use, and clinical outcomes are unknown.

NCT ID: NCT00105586 Completed - Anxiety Disorders Clinical Trials

Drug Therapy for Generalized Anxiety Disorder Among the Elderly

Start date: December 2004
Phase: Phase 4
Study type: Interventional

This study will determine the efficacy of escitalopram (Lexapro®), an anti-anxiety drug, for generalized anxiety disorder (GAD) and the ways genetics affect response to treatment for GAD in elderly individuals.

NCT ID: NCT00104195 Completed - Anxiety Disorders Clinical Trials

A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions

Start date: February 2004
Phase: Phase 1
Study type: Observational

The purpose of this trial is to study how teens with and without an anxiety disorder make decisions. This is a brain imaging study using functional magnetic resonance imaging (fMRI) in adolescents between the ages of 13 and 17.

NCT ID: NCT00104039 Completed - Clinical trials for Attention Deficit Disorder With Hyperactivity

Brain Changes in Children and Adolescents With Behavioral Problems

Start date: February 17, 2005
Phase:
Study type: Observational

Purpose: This study will examine brain activity in children age 10-18 with disruptive behavior problems, including conduct disorder (CD), oppositional defiant disorder (ODD), and attention deficit hyperactivity disorder (ADHD), compared with children without behavioral problems. Our goal is to examine differences in how emotions, social situations, and problem-solving situations are processed in the brain across these groups of children.